Clinical Pharmacology — MCQs

A 66-year-old woman presents to the emergency department after a fall 4 hours ago. She was on her way to the bathroom when she fell to the ground and lost consciousness. Although she regained consciousness within one minute, she experienced lightheadedness for almost half an hour. She has experienced on-and-off dizziness for the past 2 weeks whenever she tries to stand. She has a history of type 2 diabetes mellitus, hypertension, hypercholesterolemia, and chronic kidney disease secondary to polycystic kidneys. Her medications include aspirin, bisoprolol, doxazosin, erythropoietin, insulin, rosuvastatin, and calcium and vitamin D supplements. She has a blood pressure of 111/74 mm Hg while supine and 84/60 mm Hg on standing, the heart rate of 48/min, the respiratory rate of 14/min, and the temperature of 37.0°C (98.6°F). CT scan of the head is unremarkable. Electrocardiogram reveals a PR interval of 250 ms. What is the next best step in the management of this patient?

Q37

A 35-year-old man with a past medical history of HIV is hospitalized with a disseminated zoster infection and treated with IV acyclovir. His course of illness worsens on the 4th day after admission and his creatinine level increases to 4.2 mg/dL. Urinalysis shows birefringent needle-shaped crystals. What could have prevented this deterioration in the patient's renal function?

Q38

The contraceptive which is contraindicated in DVT is?

Q39

Which of the following is the most appropriate initial antihypertensive treatment for an elderly patient with isolated systolic hypertension?

Q40

Megaloblastic anemia should be treated with both folic acid and vitamin B12 because -

Clinical Pharmacology Indian Medical PG Practice Questions and MCQs

Question 31: Sulfasalazine is NOT used for the treatment of which of the following conditions?

A. Crohn's disease
B. Rheumatoid arthritis
C. Sarcoidosis (Correct Answer)
D. Ulcerative colitis

Explanation: **Explanation:** Sulfasalazine is a prodrug consisting of **5-aminosalicylic acid (5-ASA)** linked to **sulfapyridine** by a covalent azo bond. Its therapeutic utility is primarily derived from its anti-inflammatory and immunomodulatory properties. **Why Sarcoidosis is the Correct Answer:** Sarcoidosis is a multisystem granulomatous disease [2]. The mainstay of treatment for symptomatic sarcoidosis is **Corticosteroids** (e.g., Prednisolone). In steroid-resistant cases, second-line agents include Methotrexate, Azathioprine, or TNF-alpha inhibitors (Infliximab). Sulfasalazine has no established role in the management of sarcoidosis. **Analysis of Other Options:** * **Ulcerative Colitis (UC):** Sulfasalazine is a classic first-line agent for inducing and maintaining remission in mild-to-moderate UC [1]. The azo bond is cleaved by colonic bacteria, releasing 5-ASA (Mesalamine) directly at the site of colonic inflammation [1]. * **Crohn’s Disease:** While less effective than in UC (due to the transmural nature of Crohn's), Sulfasalazine is used for colonic involvement in Crohn’s disease [1]. * **Rheumatoid Arthritis (RA):** Sulfasalazine is classified as a **DMARD** (Disease-Modifying Anti-Rheumatic Drug). In RA, the sulfapyridine moiety is thought to be the active component responsible for systemic immunomodulation. **High-Yield Clinical Pearls for NEET-PG:** * **Mechanism:** Inhibits prostaglandin synthesis and leukotriene production. * **Side Effects:** Reversible **oligospermia** (common MCQ), megaloblastic anemia (due to folate deficiency—always supplement folic acid), and hypersensitivity reactions (Stevens-Johnson Syndrome). * **Metabolism:** Acetylation in the liver. "Slow acetylators" are at a higher risk of toxicity. * **Monitoring:** Baseline and periodic CBC and LFTs are required.

Question 32: Coloured urine is not seen in which of the following medications?

A. Quinine (Correct Answer)
B. Rifampicin
C. Nitrofurantoin
D. Pyridium

Explanation: The correct answer is **Quinine**. [1] **1. Why Quinine is the correct answer:** Quinine, an alkaloid used in the treatment of malaria, does not typically cause discoloration of the urine as a direct pharmacological effect [1]. However, it is famously associated with **"Blackwater Fever"** (massive intravascular hemolysis in *P. falciparum* malaria), which leads to hemoglobinuria (dark/black urine) [2]. In this context, the color change is a result of a pathological complication (hemolysis), not a direct property of the drug itself. **2. Analysis of Incorrect Options:** * **Rifampicin:** A classic high-yield fact. It causes a harmless **orange-red** discoloration of urine, sweat, tears, and saliva. Patients must be counseled about this to prevent poor compliance. * **Nitrofurantoin:** This urinary antiseptic commonly causes the urine to turn **brown or dark yellow**. * **Pyridium (Phenazopyridine):** Used as a urinary analgesic for cystitis, it characteristically turns urine a bright **orange to reddish-orange**. It can also stain contact lenses. **3. Clinical Pearls & High-Yield Facts for NEET-PG:** * **Red/Orange Urine:** Rifampicin, Phenazopyridine, Anthracyclines (Doxorubicin), Laxatives (Senna/Phenolphthalein). * **Brown/Black Urine:** Nitrofurantoin, Metronidazole, L-Dopa, Methyldopa, Chloroquine, Alkaptonuria (on standing). * **Blue/Green Urine:** Methylene blue, Amitriptyline, Propofol, Triamterene, Pseudomonas infection. * **Milky White Urine:** Chyluria (Filariasis), Phosphaturia. **Key Takeaway:** Always distinguish between a drug's direct pigmentary effect (Rifampicin) and a pathological complication (Quinine-induced hemolysis).

Question 33: Which drug is preferred for management of diabetes in a patient with cardiac and renal failure?

A. Pioglitazone
B. Metformin
C. SGLT2 inhibitors (Correct Answer)
D. Sulfonylureas

Explanation: ***SGLT2 inhibitors*** - These agents are strongly recommended due to their proven benefits in reducing **heart failure (HF)** hospitalizations and **cardiovascular (CV) mortality**. - They also offer robust **reno-protection**, slowing the decline of **eGFR** and reducing albuminuria, making them ideal when both cardiac and renal failure coexist. *Pioglitazone* - This drug class (**thiazolidinediones**) is known to cause **fluid retention** and peripheral edema, thus potentially exacerbating or precipitating **congestive heart failure (CHF)**; it is therefore generally avoided [1]. - It is not associated with improved long-term renal or cardiovascular outcomes in the way that SGLT2 inhibitors are. *Metformin* - While a foundational drug, Metformin is contraindicated in severe **renal failure** (e.g., eGFR <30 mL/min/1.73m²) due to the increased risk of potentially fatal **lactic acidosis**. - Although safe in mild to moderate CKD, it lacks the specific, compelling evidence for reducing progression of **heart failure** or **CKD** compared to SGLT2 inhibitors. *Sulfonylureas* - These drugs primarily increase the risk of **hypoglycemia**, which is heightened in patients with **renal insufficiency** due to altered drug metabolism and clearance. - They provide no demonstrated **cardiovascular** or **renal protective benefits** and may be associated with weight gain.

Question 34: For a 40 year old hypertensive woman, which one of the following is not recommended for contraception?

A. IUCD
B. NuvaRing (Correct Answer)
C. Minipill
D. LNG IUD (LNg IUD)

Explanation: ***NuvaRing*** - **NuvaRing** is a **combined hormonal contraceptive** that releases both estrogen and progestin. - **Estrogen-containing contraception** is generally **contraindicated** or used with caution in women with uncontrolled hypertension due to an increased risk of **cardiovascular events** such as stroke and myocardial infarction. *IUCD* - **Intrauterine contraceptive devices (IUCDs)**, both copper and levonorgestrel-releasing, are considered **safe** and highly effective for women with hypertension. - They do not contain systemic hormones or contain only progestin, which has a minimal impact on blood pressure. *Minipill* - The **minipill** is a **progestin-only oral contraceptive**. - **Progestin-only contraceptives** are safe for women with hypertension as they do not carry the same cardiovascular risks associated with estrogen. *LNG IUD (LNg IUD)* - The **levonorgestrel-releasing intrauterine device (LNG IUD)** is a **progestin-only contraceptive**. - It is **safe** for women with hypertension because the progestin is primarily local, and it does not contain estrogen, thereby avoiding cardiovascular risks.

Question 35: The initial prevention strategy for antiphospholipid syndrome will be: 1. Steroids 2. Heparin 3. Low dose aspirin 4. Progesterone support Which of the above is/are correct?

A. 1 and 4
B. 3 only
C. 3 and 4
D. 2 and 3 (Correct Answer)

Explanation: ***2 and 3*** - For pregnant women with antiphospholipid syndrome (APS), a combination of **low-dose aspirin** and **low molecular weight heparin (LMWH)** or **unfractionated heparin (UFH)** is the most widely accepted and effective initial prevention strategy to prevent pregnancy complications. - **Low-dose aspirin** helps reduce platelet aggregation, while **heparin** inhibits coagulation, addressing both thrombotic tendencies associated with APS. *1 and 4* - **Steroids** are typically reserved for severe manifestations of APS, such as catastrophic APS or refractory cases, and are not part of the initial standard preventative regimen. - **Progesterone support** is indicated for threatened miscarriage or luteal phase defect but does not address the underlying thrombotic risk in APS for pregnancy prevention. *3 only* - While **low-dose aspirin** is an important component, it is insufficient on its own for preventing pregnancy complications in women with antiphospholipid syndrome due to the high thrombotic risk. - **Heparin**, either LMWH or UFH, is crucial to provide adequate anticoagulation and is always used in conjunction with aspirin for initial prevention. *3 and 4* - **Low-dose aspirin** is appropriate, but **progesterone support** (4) is not a primary measure for preventing thrombotic events or pregnancy complications specifically linked to antiphospholipid syndrome. - The critical missing component in this option is **heparin**, which is essential for anticoagulation in APS pregnancies.

Question 36: A 66-year-old woman presents to the emergency department after a fall 4 hours ago. She was on her way to the bathroom when she fell to the ground and lost consciousness. Although she regained consciousness within one minute, she experienced lightheadedness for almost half an hour. She has experienced on-and-off dizziness for the past 2 weeks whenever she tries to stand. She has a history of type 2 diabetes mellitus, hypertension, hypercholesterolemia, and chronic kidney disease secondary to polycystic kidneys. Her medications include aspirin, bisoprolol, doxazosin, erythropoietin, insulin, rosuvastatin, and calcium and vitamin D supplements. She has a blood pressure of 111/74 mm Hg while supine and 84/60 mm Hg on standing, the heart rate of 48/min, the respiratory rate of 14/min, and the temperature of 37.0°C (98.6°F). CT scan of the head is unremarkable. Electrocardiogram reveals a PR interval of 250 ms. What is the next best step in the management of this patient?

A. Tilt table testing
B. Holter monitoring
C. Stop antihypertensive medicines (Correct Answer)
D. Electroencephalogram
E. Start anti-epileptics

Explanation: ***Stop antihypertensive medicines*** - The patient exhibits significant **orthostatic hypotension** (systolic drop of 27 mm Hg and diastolic drop of 14 mm Hg, along with lightheadedness lasting 30 minutes) [1] and **bradycardia** (48/min), suggesting that her antihypertensive medications, particularly **doxazosin** (an alpha-blocker causing vasodilation) and **bisoprolol** (a beta-blocker causing bradycardia), are contributing to her symptoms [4]. - Given her fall, lightheadedness, and profound orthostatic changes, immediately reducing or discontinuing the medications causing hypotension and bradycardia is the priority to stabilize her blood pressure and heart rate, preventing further syncopal episodes or falls [1], [4]. *Tilt table testing* - This test is primarily used to diagnose **vasovagal syncope** or **postural orthostatic tachycardia syndrome (POTS)**, often when routine orthostatic measurements are equivocal or other causes have been ruled out [2]. - In this case, the patient's orthostatic hypotension is clearly documented with current medications, and the immediate concern is medication-induced, making further diagnostic testing for this specific cause less urgent than medication adjustment. *Holter monitoring* - **Holter monitoring** is useful for detecting intermittent **cardiac arrhythmias** that may cause syncope. - While the patient has a prolonged PR interval (250 ms) indicating first-degree AV block, which rarely causes syncope on its own, her primary issue appears to be profound orthostatic hypotension [2] and bradycardia likely exacerbated by medications, rather than an uncaptured paroxysmal arrhythmia. *Electroencephalogram* - An **EEG** is indicated to diagnose **seizures** as a cause of loss of consciousness. - The patient's fall and brief loss of consciousness followed by lightheadedness align with syncope rather than a seizure [3]; her CT scan is unremarkable, and there are no typical seizure features (e.g., tonic-clonic movements, postictal confusion, tongue biting) [3]. *Start anti-epileptics* - Starting **anti-epileptics** would only be appropriate if there was strong evidence of a seizure disorder, such as clear clinical presentation of seizure or abnormal EEG findings. - There is no clinical or imaging evidence to support a seizure diagnosis in this patient; her symptoms are more consistent with cardiovascular causes, specifically medication-induced syncope [3].

Question 37: A 35-year-old man with a past medical history of HIV is hospitalized with a disseminated zoster infection and treated with IV acyclovir. His course of illness worsens on the 4th day after admission and his creatinine level increases to 4.2 mg/dL. Urinalysis shows birefringent needle-shaped crystals. What could have prevented this deterioration in the patient's renal function?

A. Initial administration of allopurinol
B. Initial administration of glucocorticoids
C. Monitoring of drug levels
D. Adequate initial hydration (Correct Answer)
E. Obtaining a thorough history of patient allergies

Explanation: Adequate initial hydration - Intravenous (IV) acyclovir is associated with **nephrotoxicity** due to the formation of **insoluble acyclovir crystals** in the renal tubules, especially in states of dehydration. - **Maintaining adequate hydration** helps in diluting the drug and preventing crystal precipitation, thereby protecting renal function. [1] *Initial administration of allopurinol* - **Allopurinol** is used to prevent **uric acid nephropathy**, typically seen in **tumor lysis syndrome**, not acyclovir-induced crystal nephropathy. [2] - Its administration would not have prevented the formation of **acyclovir crystals**. *Initial administration of glucocorticoids* - **Glucocorticoids** are potent anti-inflammatory agents but do not prevent **drug-induced crystal formation** or directly protect against acyclovir nephrotoxicity. - They are primarily used for inflammatory conditions or to suppress immune responses. *Monitoring of drug levels* - While drug level monitoring can be useful for certain medications to prevent toxicity, it's not the primary preventative measure for **acyclovir-induced crystal nephropathy**. - **Hydration** is more immediate and effective in preventing crystal precipitation. *Obtaining a thorough history of patient allergies* - An allergy history is crucial for preventing **hypersensitivity reactions** to medications, but it would not prevent **nephrotoxicity** due to crystal formation, which is a pharmacokinetic phenomenon. - The patient's renal deterioration is due to **acyclovir crystal nephropathy**, not an allergic reaction.

Question 38: The contraceptive which is contraindicated in DVT is?

A. Barrier method
B. Non hormonal IUCD
C. Billing's method
D. OCP (Correct Answer)

Explanation: ***OCP*** - **Oral contraceptive pills (OCPs)**, especially those containing estrogen, increase the risk of **venous thromboembolism (VTE)**, including deep vein thrombosis (DVT). - Estrogen promotes a **hypercoagulable state** by increasing clotting factors and decreasing natural anticoagulants. *Barrier method* - **Barrier methods** like condoms or diaphragms are non-hormonal and act physically to prevent sperm from reaching the egg. - They have **no systemic effects** on coagulation and are safe for individuals with DVT. *Non hormonal IUCD* - **Non-hormonal intrauterine contraceptive devices (IUCDs)**, such as copper IUCDs, prevent conception primarily by causing a local inflammatory reaction in the uterus. - They do not release hormones and therefore **do not affect coagulation** or increase DVT risk. *Billing's method* - The **Billing's ovulation method** (cervical mucus method) is a natural family planning technique based on observing changes in cervical mucus. - It involves no medications or devices and thus has **no impact on DVT risk**.

Question 39: Which of the following is the most appropriate initial antihypertensive treatment for an elderly patient with isolated systolic hypertension?

A. Amlodipine (Correct Answer)
B. Lisinopril
C. Atenolol
D. Losartan

Explanation: Amlodipine - **Calcium channel blockers (CCBs)**, especially dihydropyridines like amlodipine, are recommended as initial therapy for isolated systolic hypertension in the elderly due to their effectiveness in reducing elevated systolic pressure [2]. - They are well-tolerated and can reduce the risk of cardiovascular events in this population. *Lisinopril* - **ACE inhibitors** like lisinopril are effective antihypertensives but are generally not the first-line choice for isolated systolic hypertension, particularly in elderly patients where a decrease in diastolic pressure might be detrimental [1]. - They are associated with side effects such as **cough** and can cause **acute kidney injury**, which can be a concern in older adults [1]. Atenolol - **Beta-blockers** like atenolol are generally not recommended as first-line therapy for isolated systolic hypertension due to their limited efficacy in lowering systolic blood pressure compared to other drug classes. - They may also worsen certain conditions common in the elderly, such as **peripheral vascular disease** and **bronchospastic lung disease**. *Losartan* - **Angiotensin receptor blockers (ARBs)** like losartan are effective for hypertension but are not typically favored over CCBs or thiazide diuretics as initial monotherapy for isolated systolic hypertension in the elderly [1]. - They share similar side effects and contraindications with ACE inhibitors, including the risk of **renal dysfunction** [1].

Question 40: Megaloblastic anemia should be treated with both folic acid and vitamin B12 because -

A. It is an enzyme
B. It is a cofactor
C. Folic acid alone causes improvement of hematologic symptoms but worsening of neurological symptoms (Correct Answer)
D. None of the above

Explanation: ***Folic acid alone causes improvement of hematologic symptoms but worsening of neurological symptoms*** - Treating **B12 deficiency** with **folic acid alone** can normalize hematologic parameters, which can mask the underlying B12 deficiency. - This can lead to the progression of **irreversible neurological damage** because folic acid does not address the metabolic pathways dependent on B12 for myelin maintenance. *It is an enzyme* - **Folic acid** and **vitamin B12** are not enzymes; they function as **coenzymes** or **cofactors** in metabolic reactions. - Enzymes are proteins that catalyze biochemical reactions, a role not played by these vitamins themselves. *It is a cofactor* - While both **folic acid** and **vitamin B12** are cofactors, this statement alone does not explain why both are needed to treat megaloblastic anemia. - The critical reason for co-administration lies in the potential for **neurological deterioration** if B12 deficiency is missed and only folate is given. *None of the above* - This option is incorrect because there is a valid and specific reason (the neurological consequences mentioned above) for treating megaloblastic anemia with both supplements. - The interaction between **folate** and **B12 metabolism** is crucial in understanding the treatment approach.

Practice by Chapter

Pharmacokinetics and Pharmacodynamics

Practice Questions

Drug Metabolism and Excretion

Practice Questions

Adverse Drug Reactions and Interactions

Practice Questions

Therapeutic Drug Monitoring

Practice Questions

Pharmacogenomics and Precision Medicine

Practice Questions

Drug Development and Clinical Trials

Practice Questions

Rational Prescribing and Deprescribing

Practice Questions

Medication Adherence Strategies

Practice Questions

Special Populations (Pediatric, Geriatric, Pregnancy)

Practice Questions

Pharmacovigilance

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free